Search research articles
Contact Us
Filters
Showing results (31-40 of 301) with videos related to
Page
of 31
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
October 7, 2018
Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients
Adrienne Müller Herde, Roger Schibli, Markus Weber, et al.
Journal of Medicinal Chemistry
|
October 8, 2008
Synthesis, in vitro, and in silico evaluation of organometallic technetium and rhenium thymidine complexes with retained substrate activity toward human thymidine kinase type 1
Dominique Desbouis, Harriet Struthers, Vojtech Spiwok, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 3, 2009
Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy
Cristina Müller, Thomas L Mindt, Marion de Jong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 14, 2012
DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice
Cristina Müller, Harriet Struthers, Christian Winiger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 18, 2008
Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer
Cristina Müller, Roger Schibli, Eric P Krenning, et al.
Molecular Pharmaceutics
|
March 5, 2010
Effects of the antifolates pemetrexed and CB3717 on the tissue distribution of (99m)Tc-EC20 in xenografted and syngeneic tumor-bearing mice
Cristina Müller, Joseph A Reddy, Christopher P Leamon, et al.
EJNMMI Research
|
July 10, 2014
A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelator
Andreas Jodal, Brigitte Lankat-Buttgereit, Maarten Brom, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 12, 2021
Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease
Caitlin V M L Jie, Valerie Treyer, Roger Schibli, et al.
Molecular Pharmaceutics
|
February 12, 2013
In vitro and in vivo evaluation of an innocuous drug cocktail to improve the quality of folic acid targeted nuclear imaging in preclinical research
Cristina Müller, Josefine Reber, Claudia Schlup, et al.
EJNMMI Radiopharmacy and Chemistry
|
October 30, 2019
Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
Simon A M Kaeppeli, Roger Schibli, Thomas L Mindt, et al.
Page
of 31
Search research articles
Search
Showing results (31-40 of 301) with videos related to
Sort By:
Page
of 31
European Journal of Nuclear Medicine and Molecular Imaging
|
October 7, 2018
Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients
Adrienne Müller Herde, Roger Schibli, Markus Weber, et al.
Journal of Medicinal Chemistry
|
October 8, 2008
Synthesis, in vitro, and in silico evaluation of organometallic technetium and rhenium thymidine complexes with retained substrate activity toward human thymidine kinase type 1
Dominique Desbouis, Harriet Struthers, Vojtech Spiwok, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 3, 2009
Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy
Cristina Müller, Thomas L Mindt, Marion de Jong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 14, 2012
DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice
Cristina Müller, Harriet Struthers, Christian Winiger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 18, 2008
Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer
Cristina Müller, Roger Schibli, Eric P Krenning, et al.
Molecular Pharmaceutics
|
March 5, 2010
Effects of the antifolates pemetrexed and CB3717 on the tissue distribution of (99m)Tc-EC20 in xenografted and syngeneic tumor-bearing mice
Cristina Müller, Joseph A Reddy, Christopher P Leamon, et al.
EJNMMI Research
|
July 10, 2014
A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelator
Andreas Jodal, Brigitte Lankat-Buttgereit, Maarten Brom, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 12, 2021
Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease
Caitlin V M L Jie, Valerie Treyer, Roger Schibli, et al.
Molecular Pharmaceutics
|
February 12, 2013
In vitro and in vivo evaluation of an innocuous drug cocktail to improve the quality of folic acid targeted nuclear imaging in preclinical research
Cristina Müller, Josefine Reber, Claudia Schlup, et al.
EJNMMI Radiopharmacy and Chemistry
|
October 30, 2019
Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
Simon A M Kaeppeli, Roger Schibli, Thomas L Mindt, et al.
Page
of 31